Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Critical Therapeutics grosses $54.5mm with private placement

Executive Summary

Critical Therapeutics has grossed $54.5mm with a private placement of about 9.9mm common shares at $5.48 each (a 4% discount to the market average) to existing investors Prospect Venture Partners (2.3mm shares), Advanced Technology Ventures (1.3mm shares), HealthCare Ventures (1.1mm shares), and MPM Asset Management (547k shares).
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
Deal Status
  • Final
Deal Type
  • Financing
    • Private Investment in Public Equity
    • Private Placement

Related Companies